Trial Profile
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 May 2019
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Clarithromycin
- Indications Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb; Pfizer
- 27 Apr 2019 Results published in the American Journal of Cardiovascular Drugs
- 18 Nov 2016 Status changed from recruiting to completed.
- 06 Oct 2016 Status changed from not yet recruiting to recruiting.